Public Meeting with FDA Oct. 19 Will Focus on Potency Assays for CGTs

David Barrett, JD - October 06, 2022

Register for free for this meeting that ASGCT is co-hosting with ARM.

Join us Oct. 19 for a public meeting with FDA on potency assays for cell and gene therapies.

Cohosted with the Alliance for Regenerative Medicine (ARM), the virtual meeting will be held from 9 a.m. to 4 p.m. (ET). You can register using this link to the main room or this link to the breakout room, and bring your questions for a brief Q&A during the event.

View the Agenda       Register Now

David Barrett, JD, is CEO of ASGCT.